THE APPLICATION/ABSTRACT DEADLINE IS MIDNIGHT EASTERN TIME, THURSDAY, APRIL 1, 2010.
The Organizing Committee requires that presenting authors submit their abstracts electronically via this website. Abstract submissions will only be accepted from the presenting author. All correspondence regarding the status of the abstract will be sent only to the presenting author.

As in previous years, the abstract/application process has been combined into one online step. There is no need to complete the application/abstract form until your abstract is ready for submission.

To submit an abstract, click on the button at the bottom of the page and follow the step-by-step directions, which will enable you to provide the presenting author contact information, answer a few questions, and then upload the file containing your abstract from the computer system that you are using to access this website. To ensure your abstract retains any special characters or formatting, the abstract must be in MICROSOFT WORD format.

Multiple submissions from the same data set will jeopardize abstract acceptance. The Organizing Committee requires submission of a single abstract from the entire group involved in the study.

Each applicant may submit a MAXIMUM of two (2) abstracts. If more than two (2) abstracts are submitted, only the last 2 submissions will be evaluated. Those authors of abstracts not accepted will be considered for acceptance with those applicants not submitting an abstract. For each accepted abstract, one registration slot will be awarded to the presenting author.

Co-authors of abstracts must complete an application to be considered for admittance into the Workshop.

ABSTRACT CATEGORY
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Organizing Committee reserves the right to reassign your abstract to a more appropriate category.

           • Resistance to New Antiretroviral Agents
           • Mechanisms of HIV Drug Resistance
           • HIV Pathogenesis, Fitness and Resistance
           • Clinical Implications of Resistance
           • Epidemiology
           • New Resistance Technologies and Interpretations
           • HBV Drug Resistance
           • HCV Drug Resistance
           • Drug Resistance in Resource Poor Countries
           • Persistence, Reservoirs and Elimination Strategies

For guidelines on formatting the abstract, click here.

PUBLISHED ABSTRACT BOOK
Accepted abstracts will be standardized in font and presentation. Any scientific error that appears in the submitted abstract will appear in the printed abstract.